All sponsors

Haihe Biopharma Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-30
RECRUITING4
READOUTS ≤12 MONTHS0
Open Haihe Biopharma Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Glumetinib
NCT04270591
P1/2RecruitingC-Met Exon 14 Mutation1832023-10-25
CYH33
NCT05043922
P2Active, not recruitingOvarian Cancer; Recurrent Cancer932024-07-31 (+13 mo)
HH2853 Tablets
NCT06909877
P1/2RecruitingRelapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)1002025-10-31
HH2853 Tablets
NCT04390737
P1/2RecruitingFL Lymphoma; Epithelioid Sarcoma2542027-12-31 (+82 mo)
CYH33
NCT06975618
P1/2RecruitingPIK3CA-Related Overgrowth Spectrum (PROS); PIK3CA-related Vascular Malformations (PRVM)1412029-12-31